Lehtokari Vilma-Lotta, Pelin Katarina, Sandbacka Maria, Ranta Salla, Donner Kati, Muntoni Francesco, Sewry Caroline, Angelini Corrado, Bushby Kate, Van den Bergh Peter, Iannaccone Susan, Laing Nigel G, Wallgren-Pettersson Carina
The Folkhälsan Institute of Genetics and the Department of Medical Genetics, University of Helsinki, Helsinki, Finland.
Hum Mutat. 2006 Sep;27(9):946-56. doi: 10.1002/humu.20370.
Nemaline myopathy (NM) is a clinically and genetically heterogeneous disorder of skeletal muscle caused by mutations in at least five different genes encoding thin filament proteins of the striated muscle sarcomere. We have previously described 18 different mutations in the last 42 exons of the nebulin gene (NEB) in 18 families with NM. Here we report 45 novel NEB mutations detected by denaturing high-performance liquid chromatography (dHPLC) and sequence analysis of all 183 NEB exons in NM patients from 44 families. Altogether we have identified, including the deletion of exon 55 identified in the Ashkenazi Jewish population, 64 different mutations in NEB segregating with autosomal recessive NM in 55 families. The majority (55%) of the mutations in NEB are frameshift or nonsense mutations predicted to cause premature truncation of nebulin. Point mutations (25%) or deletions (3%) affecting conserved splice signals are predicted in the majority of cases to cause in-frame exon skipping, possibly leading to impaired nebulin-tropomyosin interaction along the thin filament. Patients in 18 families had one of nine missense mutations (14%) affecting conserved amino acids at or in the vicinity of actin or tropomyosin binding sites. In addition, we found the exon 55 deletion in four families. The majority of the patients (in 49/55 families) were shown to be compound heterozygous for two different mutations. The mutations were found in both constitutively and alternatively expressed exons throughout the NEB gene, and there were no obvious mutational hotspots. Patients with more severe clinical pictures tended to have mutations predicted to be more disruptive than patients with milder forms.
杆状体肌病(NM)是一种临床和遗传异质性的骨骼肌疾病,由至少五个不同基因的突变引起,这些基因编码横纹肌肌节的细肌丝蛋白。我们之前在18个患有NM的家族中描述了nebulin基因(NEB)最后42个外显子中的18种不同突变。在此,我们报告通过变性高效液相色谱(dHPLC)和对来自44个家族的NM患者的所有183个NEB外显子进行序列分析检测到的45个新的NEB突变。包括在德系犹太人中鉴定出的外显子55缺失在内,我们总共在55个家族中鉴定出64种不同的NEB突变,这些突变与常染色体隐性NM共分离。NEB中的大多数突变(55%)是移码或无义突变,预计会导致nebulin过早截断。在大多数情况下,影响保守剪接信号的点突变(25%)或缺失(3%)预计会导致框内外显子跳跃,可能导致沿细肌丝的nebulin-原肌球蛋白相互作用受损。18个家族中的患者有9种错义突变之一(14%),这些突变影响肌动蛋白或原肌球蛋白结合位点处或其附近的保守氨基酸。此外,我们在四个家族中发现了外显子55缺失。大多数患者(49/55个家族)被证明是两种不同突变的复合杂合子。这些突变在整个NEB基因的组成型和可变表达外显子中均有发现,且没有明显的突变热点。临床症状较重的患者往往比症状较轻的患者具有预计更具破坏性的突变。